By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Dana-Farber Cancer Institute 

44 Binney Street

Boston  Massachusetts  02115  U.S.A.
Phone: 617-632-3000 Fax: n/a

The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. As an affiliate of Harvard Medical School and a Comprehensive Cancer Center designated by the National Cancer Institute, the Institute also provides training for new generations of physicians and scientists, designs programs that promote public health particularly among high-risk and underserved populations, and disseminates innovative patient therapies and scientific discoveries to our target community across the United States and throughout the world.


Dana-Farber Cancer Institute's ultimate goal is the eradication of cancer, AIDS, and related diseases and the fear that they engender.

Core Values


Above all else, we make a difference by relieving the burden of disease now and for the future through our research, clinical care, education, outreach and advocacy.

We pursue excellence relentlessly and with integrity in all that we do, adhering always to the highest standards of conduct.

Compassion and Respect
For those in our care and for one another.

We foster the spirit of inquiry, promoting collaboration and innovation across traditional boundaries while celebrating individual creativity.

Key Statistics

Ownership: Private

Web Site: Dana-Farber Cancer Institute

Company News
Evidence Of Link Between Cancer & Light Therapy Inconclusive But Warrants Consideration, Dana-Farber Cancer Institute Study 5/23/2016 7:52:53 AM
Dana-Farber Cancer Institute And Fitbit (FIT) Partner To Test If Weight Loss Can Prevent Breast Cancer Recurrence 4/27/2016 10:39:49 AM
The Tumor Trail Left In Blood, Dana-Farber Cancer Institute Study 4/19/2016 8:10:19 AM
Bristol-Myers Squibb (BMY) And Dana-Farber Cancer Institute Enter Into A Collaboration Agreement As Part Of U.S. Immuno-Oncology Rare Population Malignancy Research Program 2/16/2016 11:13:04 AM
Dana-Farber Cancer Institute's Belfer Center Announces Immuno-Oncology Research Collaboration With Array BioPharma (ARRY) 2/1/2016 10:11:14 AM
Transgenomic, Inc. (TBIO) Awarded NIH Grant To Augment Multiplexing Capabilities Of ICE COLD-PCR Technology In Collaboration With Dana-Farber Cancer Institute 12/23/2015 10:48:11 AM
Neon Therapeutics Enters License Agreement With The Broad Institute, Dana-Farber Cancer Institute And Massachusetts General Hospital 12/9/2015 10:25:27 AM
Pan-Mass Challenge Announces Record-Setting $45 Million Gift To Dana-Farber Cancer Institute, Bringing 36-Year Fundraising Total To A Half-Billion Dollars 11/16/2015 10:07:59 AM
TRACON Pharmaceuticals, Inc. (TCON) Reports Ongoing Complete Response In Choriocarcinoma Patient Treated With Company's TRC105 In Compassionate Use Phase 2 Clinical Trial Conducted At Dana-Farber Cancer Institute 9/18/2015 6:57:17 AM
Drinking Coffee Daily May Boost Colon Cancer Survival, Dana-Farber Cancer Institute Study 8/18/2015 6:43:06 AM